Schott Pharma AG & CO KGaA (OTCPK:SHTPY)

Q1 2026 SCHOTT Pharma AG & Co KgaA Earnings Call Transcript

Feb 11, 2026 / 10:00 AM GMT

Release Date Price: $4.37

Transcript

Key Points

Positve

Revenue for Q1 2026 increased by 4.8% at constant currencies to €240 million, driven by strong demand across the portfolio.
EBITDA grew significantly by 11% to €65 million, resulting in a strong margin of 27.1%, primarily due to high-value solutions.
The company launched innovative products like Elio amber vials and prevalidated new polymer cartridges, setting industry benchmarks.
Schott Pharma AG & CO KGaA is expanding capacities for high-value solutions in Switzerland and Hungary, focusing on large volume solutions.
Net income increased by 12% year on year to €33.3 million, reflecting strong financial performance.

Negative

Cash flow from operating activities was significantly below the prior year at €3.4 million, impacted by a deferred payment.
The drug delivery systems segment saw a decline in EBITDA by 7.3% due to product mix effects and lower production utilization.
The reduced use of mRNA vaccines negatively affected polymer syringes, contributing to a slight decline in the segment.
Free cash flow amounted to €-20 million in the first quarter, mainly impacted by the deferred payment.
The company faces ongoing market volatility, which affects its ability to provide specific quarterly guidance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

1SXP.DE - SCHOTT Pharma AG & Co KgaA
Q1 2026 SCHOTT Pharma AG & Co KgaA Earnings Call
Feb 11, 2026 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you, Anna. Good morning, everyone, and welcome to Schwartz Farmers earnings call for the first quarter of financial year 2026.

My name is Tobias Erfurt, head of investor relations, and I will be guiding you through today's call and webcast. I'm joined by our CEO Andreas Reiser and our CFO Reinard Meyer.

Andreas will start by sharing strategic and business updates, followed by Reiner, who will present our financial performance in detail.

Afterwards, we open the floor for your questions.

Please take a moment to review our disclaimer.

And as a quick note, our financial year 2026 has started on October 1st, 2025. So the Q1 results we are presenting today cover the

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.